Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q1 2026 ▲▼ | Q2 2026 ▲▼ | Change ▲▼ | Q1 2026 ▲▼ | Q2 2026 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Avalyn Pharmaceuticals Inc | 0 | 1,675,830 | +1,675,830 | $0 | $55.17M | 10.37% | +$55.17M |
| Johnson & Johnson(JNJ) | 0 | 138,946 | +138,946 | $0 | $35.29M | 6.63% | +$35.29M |
| Gilead Sciences, Inc.(GILD) | 163,905 | 269,309 | +105,404 | $22.84M | $34.02M | 6.39% | +$11.18M |
| BridgeBio Pharma, Inc.(BBIO) | 432,014 | 455,041 | +23,027 | $32.08M | $33.89M | 6.37% | +$1.81M |
| Syndax Pharmaceuticals, Inc.(SNDX) | 1,043,670 | 1,215,698 | +172,028 | $24.38M | $26.58M | 4.99% | +$2.20M |
| Definium Therapeutics, Inc.(DFTX) | 1,037,984 | 562,672 | -475,312 | $19.62M | $26.47M | 4.97% | +$6.85M |
| Bristol-Myers Squibb Company(BMY) | 420,727 | 412,961 | -7,766 | $25.52M | $23.79M | 4.47% | -$1.72M |
| Parabilis Medicines Inc | 0 | 824,043 | +824,043 | $0 | $22.55M | 4.24% | +$22.55M |
| Natera, Inc.(NTRA) | 70,907 | 82,181 | +11,274 | $14.18M | $22.31M | 4.19% | +$8.13M |
| Incyte Corporation(INCY) | 182,101 | 191,627 | +9,526 | $17.14M | $21.72M | 4.08% | +$4.58M |
| Septerna, Inc.(SEPN) | 294,360 | 536,152 | +241,792 | $7.07M | $17.96M | 3.37% | +$10.88M |
| Mineralys Therapeutics, Inc.(MLYS) | 439,041 | 648,722 | +209,681 | $11.89M | $17.50M | 3.29% | +$5.61M |
| Heartflow, Inc.(HTFL) | 403,588 | 583,055 | +179,467 | $9.82M | $17.11M | 3.21% | +$7.29M |
| Corvus Pharmaceuticals, Inc.(CRVS) | 891,933 | 1,080,888 | +188,955 | $13.05M | $16.15M | 3.03% | +$3.10M |
| Structure Therapeutics IncADS | 255,379 | 276,550 | +21,171 | $12.31M | $14.84M | 2.79% | +$2.53M |
| Protagonist Therapeutics Inc | 0 | 106,799 | +106,799 | $0 | $13.09M | 2.46% | +$13.09M |
| Disc Medicine, Inc.(IRON) | 122,978 | 159,384 | +36,406 | $7.86M | $11.66M | 2.19% | +$3.79M |
| Edwards Lifesciences Corp | 144,607 | 124,778 | -19,829 | $11.58M | $11.29M | 2.12% | -$292.7K |
| Axsome Therapeutics, Inc.(AXSM) | 0 | 43,182 | +43,182 | $0 | $10.57M | 1.99% | +$10.57M |
| Ultragenyx Pharmaceutical Inc.(RARE) | 850,797 | 316,252 | -534,545 | $17.82M | $10.56M | 1.98% | -$7.26M |
| Kailera Therapeutics Inc | 0 | 468,750 | +468,750 | $0 | $10.33M | 1.94% | +$10.33M |
| Karyopharm Therapeutics Inc.(KPTI) | 897,709 | 940,855 | +43,146 | $5.00M | $9.19M | 1.73% | +$4.19M |
| Odyssey Therapeutics Inc | 0 | 457,839 | +457,839 | $0 | $8.57M | 1.61% | +$8.57M |
| Ascendis Pharma A/S(ASND) | 0 | 31,759 | +31,759 | $0 | $8.47M | 1.59% | +$8.47M |
| Kardigan Inc | 0 | 312,500 | +312,500 | $0 | $7.45M | 1.40% | +$7.45M |
| Eledon Pharmaceuticals, Inc.(ELDN) | 1,639,816 | 1,695,071 | +55,255 | $5.05M | $6.68M | 1.26% | +$1.63M |
| 4d Molecular Therapeutics In | 0 | 471,254 | +471,254 | $0 | $6.27M | 1.18% | +$6.27M |
| Veradermics, Incorporated(MANE) | 173,582 | 45,856 | -127,726 | $10.96M | $5.64M | 1.06% | -$5.32M |
| Dyne Therapeutics, Inc.(DYN) | 282,954 | 244,929 | -38,025 | $5.13M | $5.44M | 1.02% | +$309.9K |
| Fractyl Health, Inc.(GUTS) | 5,491,866 | 6,168,749 | +676,883 | $2.51M | $4.90M | 0.92% | +$2.39M |
| Immunocore Holdings plcADS(IMCR) | 84,352 | 148,045 | +63,693 | $2.54M | $4.70M | 0.88% | +$2.16M |
| Dianthus Therapeutics, Inc.(DNTH) | 560,308 | 32,941 | -527,367 | $47.02M | $3.21M | 0.60% | -$43.81M |
| BridgeBio Oncology Therapeutics, Inc.(BBOT) | 0 | 318,407 | +318,407 | $0 | $2.43M | 0.46% | +$2.43M |
| Protara Therapeutics, Inc.(TARA) | 580,024 | 520,148 | -59,876 | $3.02M | $1.99M | 0.37% | -$1.03M |
| Hyperfine, Inc.CL A(HYPR) | 1,320,041 | 1,320,041 | 0 | $1.43M | $1.78M | 0.33% | +$356.4K |
| Ataibeckley Inc | 196,858 | 196,858 | 0 | $696.9K | $1.04M | 0.19% | +$340.6K |
| Metagenomi Therapeutics, Inc.(MGX) | 528,993 | 528,993 | 0 | $708.9K | $629.5K | 0.12% | -$79.3K |
| Outset Medical, Inc.(OM) | 118,279 | 118,279 | 0 | $454.2K | $511.0K | 0.10% | +$56.8K |
| Faeth Therapeutics, Inc.(FTH) | 14,718 | 14,718 | 0 | $463.9K | $367.9K | 0.07% | -$96.0K |
| ABIVAX Société AnonymeADS(ABVX) | 47,193 | 0 | -47,193 | $5.25M | $0 | — | -$5.25M |
| Adaptive Biotechnologies Corporation(ADPT) | 722,784 | 0 | -722,784 | $10.03M | $0 | — | -$10.03M |
| Ascendis Pharma A/SADR(ASND) | 129,111 | 0 | -129,111 | $29.53M | $0 | — | -$29.53M |
| Boston Scientific Corporation(BSX) | 299,318 | 0 | -299,318 | $18.78M | $0 | — | -$18.78M |
| Cytokinetics, Incorporated(CYTK) | 215,501 | 0 | -215,501 | $14.20M | $0 | — | -$14.20M |
| Kalvista Pharmaceuticals Inc | 426,551 | 0 | -426,551 | $8.59M | $0 | — | -$8.59M |
| Newamsterdam Pharma Company ORDINARY SHARES | 83,554 | 0 | -83,554 | $2.67M | $0 | — | -$2.67M |
| Phathom Pharmaceuticals, Inc.(PHAT) | 247,767 | 0 | -247,767 | $2.75M | $0 | — | -$2.75M |
| uniQure N.V.SHS(QURE) | 491,116 | 0 | -491,116 | $8.03M | $0 | — | -$8.03M |
| Soleno Therapeutics Inc | 577,808 | 0 | -577,808 | $19.35M | $0 | — | -$19.35M |
| Supernus Pharmaceuticals, Inc.(SUPN) | 62,019 | 0 | -62,019 | $3.21M | $0 | — | -$3.21M |
| Terns Pharmaceuticals Inc | 409,031 | 0 | -409,031 | $21.56M | $0 | — | -$21.56M |
| Tyra Biosciences, Inc.(TYRA) | 67,285 | 0 | -67,285 | $2.58M | $0 | — | -$2.58M |